» Articles » PMID: 1335519

Decreased Alpha 1-adrenergic Receptors After Experimental Brain Injury

Overview
Journal J Neurotrauma
Publisher Mary Ann Liebert
Date 1992 Jan 1
PMID 1335519
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The magnitude of neuronal damage in central nervous system (CNS) injury may be related, in part, to alterations in the balance between excitatory and inhibitory neurotransmitters. Previous studies have implicated a role of central inhibitory noradrenergic mechanisms in the pathophysiologic sequelae of traumatic brain injury. In the present study, we examined alpha 1-adrenergic receptor binding after parasaggital lateral fluid percussion (FP) brain injury of moderate severity (2.3 atm) in the rat. At 30 min following injury, the specific binding of [3H]prazosin to membranes isolated from left cortex (injury site) was reduced by 37% in brain-injured animals when compared to sham-operated noninjured animals (p < 0.05). However, there were no significant differences in [3H]prazosin binding to membranes of either contralateral (right) cortex or left and right hippocampi between brain-injured and sham-operated animals. Conversely, at 24 h posttrauma, specific binding to membranes of left cortex, cortex adjacent to injury site, contralateral (right) cortex, and left hippocampus was reduced by 25%, 16%, 27%, and 24%, respectively (all p < 0.05). Scatchard analysis revealed that a reduction of [3H]prazosin binding to membranes of injured animals resulted from a decrease in alpha 1-receptor binding density (B-max) but not from changes in ligand affinity. Histopathologic assessment of neuronal damage at 24 h postinjury revealed neuronal loss within injury site cortex and left hippocampus but no clearly discernible cell loss in contralateral right cortex, suggesting that the decrease in B-max might be a consequence of early pathophysiology of trauma rather than of neuronal cell loss. We suggest that alterations in alpha 1-adrenergic receptors after brain injury may result in decreased inhibitory neurotransmitter action of norepinephrine and may thus contribute to the pathophysiology of traumatic brain injury.

Citing Articles

Milnacipran Ameliorates Executive Function Impairments following Frontal Lobe Traumatic Brain Injury in Male Rats: A Multimodal Behavioral Assessment.

Craine T, Race N, Kutash L, Iouchmanov A, Moschonas E, ONeil D J Neurotrauma. 2022; 40(1-2):112-124.

PMID: 35979888 PMC: 10024072. DOI: 10.1089/neu.2022.0289.


DNA methylation under the major depression pathway predicts pediatric quality of life four-month post-pediatric mild traumatic brain injury.

Duan K, Mayer A, Shaff N, Chen J, Lin D, Calhoun V Clin Epigenetics. 2021; 13(1):140.

PMID: 34247653 PMC: 8274037. DOI: 10.1186/s13148-021-01128-z.


Executive (dys)function after traumatic brain injury: special considerations for behavioral pharmacology.

Ozga J, Povroznik J, Engler-Chiurazzi E, Vonder Haar C Behav Pharmacol. 2018; 29(7):617-637.

PMID: 30215621 PMC: 6155367. DOI: 10.1097/FBP.0000000000000430.


Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies.

McGuire J, Ngwenya L, McCullumsmith R Mol Psychiatry. 2018; 24(7):995-1012.

PMID: 30214042 DOI: 10.1038/s41380-018-0239-6.


Trovafloxacin attenuates neuroinflammation and improves outcome after traumatic brain injury in mice.

Garg C, Seo J, Ramachandran J, Loh J, Calderon F, Contreras J J Neuroinflammation. 2018; 15(1):42.

PMID: 29439712 PMC: 5812039. DOI: 10.1186/s12974-018-1069-9.